CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson’s Disease
Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYNin skin biopsies using CND's Syn-One Test® CND Life Sciences(CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announcedthat it has been awarded a $4.2M grant fromThe Michael J. Fox Foundation for […]